Figure 4. Mean hemoglobin (Hgb) change from baseline over time by randomized treatment group (mITT population). Data are mean ± SD but were not calculated if the number of patients was ≤ 3. LEN indicates lenalidomide.
Figure 4

Mean hemoglobin (Hgb) change from baseline over time by randomized treatment group (mITT population). Data are mean ± SD but were not calculated if the number of patients was ≤ 3. LEN indicates lenalidomide.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal